Clinical Trial Update: Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Aclarubicin in combination with cyclophosphamide, vincristine, and prednisone (CAOP) in patients with previously treated c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Sezary Syndrome

Drugs mentioned

• Aclarubicin (aclarubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING